The information collection supports agency requirements regarding the registration of blood establishments and the listing of blood products. The information obtained through the registration and product listing of domestic and foreign blood establishments assists FDA in its inspections of facilities. This information is essential to the overall regulatory scheme designed to ensure the safety of the nation's blood supply.
The latest form for Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices expires 2021-06-30 and can be found here.
Federal Enterprise Architecture: Health - Consumer Health and Safety